JournalTOCs

Gastroenterology Clinics of North America
Journal Prestige (SJR): 1.537

Citation Impact (citeScore): 3
Number of Followers: 8

Full-text available via subscription

Subscription journal
ISSN (Print) 0889-8553
Published by Elsevier

[3163 journals]

Nutritional Management of Gastrointestinal Disease
- Authors: Andrew Ukleja
  Abstract: Publication date: March 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 1
  Author(s): Andrew Ukleja
  
  PubDate: 2018-02-15T08:34:54Z
  DOI: 10.1016/s0889-8553(17)30146-2
The Role of Diet in the Treatment of Irritable Bowel Syndrome
- Authors: Rajdeep Singh; Ahmed Salem; Julie Nanavati; Gerard E. Mullin
  Pages: 107 - 137
  Abstract: Publication date: March 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 1
  Author(s): Rajdeep Singh, Ahmed Salem, Julie Nanavati, Gerard E. Mullin
  Teaser Irritable bowel syndrome (IBS) is a multifaceted illness involving maladaptive shifts in the gut microbiota that affect the enteric nervous and immune systems, mucosal barrier function, the balance of neurotransmitters and hormones, and emotional well-being. There is abundant evidence indicating that certain foods elicit symptoms in IBS. Numerous elimination-type diets have been shown to alleviate symptoms. However, among these, the most controversial is a group of foods called fructo, oligo-, di-, and monosaccharides and polyols (FODMAPs). This paper reviews the role of diet and systematically analyze the literature for the role of FODMAPs in IBS.
  
  PubDate: 2018-02-15T08:34:54Z
  DOI: 10.1016/j.gtc.2017.10.003
The Need to Reassess Dietary Fiber Requirements in Healthy and Critically
Ill Patients
- Authors: Stephen J.D. O’Keefe
  Pages: 219 - 229
  Abstract: Publication date: March 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 1
  Author(s): Stephen J.D. O’Keefe
  Teaser This article provides evidence that current dietary fiber intake levels may be insufficient to maintain colonic mucosal health and defense, and reduce inflammation and cancer risk in otherwise healthy people. Current commercial tube feeds generally overlook the metabolic needs of the colon and may predispose patients to dysbiosis, bacterial overgrowth with pathogens such as Clostridium difficile, and acute colitis. These results raise concern about the wide-scale use of prophylactic antibiotics in the intensive care unit and the use of elemental, fiber-depleted tube feeds. Nutrition support is not complete without the addition of sufficient fiber to meet colonic nutritional needs.
  
  PubDate: 2018-02-15T08:34:54Z
  DOI: 10.1016/j.gtc.2017.10.005
Gastrointestinal Transplantation
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Enrico Benedetti, Ivo G. Tzvetanov
  
  PubDate: 2018-05-28T20:02:13Z
Forthcoming Issues
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  
  PubDate: 2018-05-28T20:02:13Z
Transplantation of Abdominal Organs
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Alan L. Buchman
  
  PubDate: 2018-05-28T20:02:13Z
Living Donor Liver Transplantation
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Kiara A. Tulla, Hoonbae Jeon
  Teaser Living donor liver transplantation (LDLT) has found a place to serve the end-stage liver disease community as the donor safety and recipient suitability has been elucidated. Donor safety is of paramount importance and transplant programs must continue endeavors to maintain the highest possible standards. At the same time, adequacy of grafts based on recipient clinical status via their model for end-stage liver disease (MELD) score and volumetric studies to achieve a GRBWR >0.8, along with special attention to anatomic tailoring and portal venous flow optimization are necessary for successful transplantation. Technical innovations have improved sequentially the utility and availability of LDLT.
  
  PubDate: 2018-05-28T20:02:13Z
Liver Transplant for Cholangiocarcinoma
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Daniel Zamora-Valdes, Julie K. Heimbach
  Teaser Liver transplant (LT) for perihilar cholangiocarcinoma (CCA) offers an opportunity for survival among patients with early-stage but anatomically unresectable disease. The 5-year survival rate after LT is 65% to 70%, higher among patients with primary sclerosing cholangitis, who are often diagnosed earlier, and lower among patients with de novo CCA. The results of LT for hilar CCA, along with recent limited data suggesting favorable survival among patients with very early intrahepatic CCA (ICC), have reignited interest in the subject. This article discusses LT following neoadjuvant therapy for CCA and the early data on LT alone for ICC.
  
  PubDate: 2018-05-28T20:02:13Z
Immunologic Monitoring to Personalize Immunosuppression After Liver
Transplant
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Andrew Zhu, Alexandra Leto, Abraham Shaked, Brendan Keating
  Teaser Although immunosuppressive drugs have enhanced patient outcomes in transplantation, the liver transplant community has made significant research efforts into the discovery of more accurate and precise methods of posttransplant monitoring and diagnosing. Current research in biomarkers reveals many promising approaches.
  
  PubDate: 2018-05-28T20:02:13Z
Status of Adult Living Donor Liver Transplantation in the United States
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Samir Abu-Gazala, Kim M. Olthoff
  Teaser This article reviews the Adult-to-Adult Living Donor Liver Transplant Cohort Study (A2ALL). The findings show that the number of adult-to-adult living donor liver transplants is consistently increasing. Living donor liver transplantation has an important benefit for patients with acute liver failure, does not compromise donor safety, and has lower rates of acute cellular rejection in biologically related donor and recipient. The conclusions from the A2ALL consortium have been critical in transplant advancement, supporting increased use to help decrease waitlist death and improve long-term survival of transplant recipients.
  
  PubDate: 2018-05-28T20:02:13Z
Endoscopic Follow-up of Intestinal Transplant Recipients
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Robert E. Carroll
  Teaser The growing population of intestinal transplant recipients present a unique challenge to the gastroenterologists responsible for their support and evaluation. Improvements in patient and graft survival are largely attributed to surgical advancements, refined antirejection therapy, and enhanced endoscopic surveillance protocols that better perceive rejection and other complications. This article reviews the endoscopic management and interventions provided for transplant recipients at the University of Illinois Hospital with complications, such as acute rejection, ischemia, bleeding, fistula, post-transplant lymphoproliferative disorder, and gastroparesis. Further research is needed on promising strategies currently used for related diseases to treat and sustain the intestinal graft.
  
  PubDate: 2018-05-28T20:02:13Z
Composite and Multivisceral Transplantation
- Abstract: Publication date: June 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 2
  Author(s): Guilherme Costa, Neha Parekh, Mohammed Osman, Sherif Armanyous, Masato Fujiki, Kareem Abu-Elmagd
  Teaser The successful development of multivisceral and composite visceral transplantation is among the milestones in the recent history of human organ transplantation. All types of gastrointestinal transplantation have evolved to be the standard of care for patients with gut failure and complex abdominal pathologic conditions. The outcome has markedly improved over the last 3 decades owing to technical innovation, novel immunosuppression, and better postoperative care. Recent data documented significant improvement in the long-term therapeutic indices of all types of visceral transplantation close to that achieved with thoracic and solid abdominal organs.
  
  PubDate: 2018-05-28T20:02:13Z
Adult Intestinal Transplantation
- Authors: Cal S. Matsumoto; Sukanya Subramanian; Thomas M. Fishbein
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Cal S. Matsumoto, Sukanya Subramanian, Thomas M. Fishbein
  Teaser Adult intestinal transplantation differs significantly from pediatric intestinal transplantation. While indications have remained largely consistent since 2000, indications for adults have expanded over the last two decades to include motility disorders and desmoid tumors. Graft type in adult recipients depends on the distinct anatomic characteristics of the adult recipient. Colonic inclusion, while initially speculated to portend unfavorable outcomes due to complex host-bacterial interactions has increased over the past two decades with superior graft survival and improved patient quality of life. Overall, outcomes have steadily improved. For adult intestinal transplant candidates, intestinal transplantation remains a mainstay therapy for complicated intestinal failure and is a promising option for other life threatening and debilitating conditions.
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.011
Pediatric Intestinal Transplantation
- Authors: Neslihan Celik; George V. Mazariegos; Kyle Soltys; Jeffrey A. Rudolph; Yanjun Shi; Geoffrey J. Bond; Rakesh Sindhi; Armando Ganoza
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Neslihan Celik, George V. Mazariegos, Kyle Soltys, Jeffrey A. Rudolph, Yanjun Shi, Geoffrey J. Bond, Rakesh Sindhi, Armando Ganoza
  Teaser Pediatric intestinal transplantation has moved from the theoretic to an actual therapy for children with irreversible intestinal failure who are suffering from complications of total parenteral nutrition. Owing to significant advancement in the management of intestinal failure and prevention of parenteral nutrition-related complications that have led to reduction in incidence of parenteral nutrition-associated liver disease and have improved intestinal adaptation, the indications for intestinal transplantation are evolving. Long-term outcomes have improved, but challenges in long-term graft function owing to chronic rejection and immunosuppressant-related complications remain the major opportunities for improvement.
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.007
Intestinal Failure and Rehabilitation
- Authors: Alan L. Buchman
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Alan L. Buchman
  Teaser The rendering of proper care for the patient with intestinal failure requires the provider to have a functional understanding of digestion and absorption, nutrient requirements, and intestinal adaptation. Inherent in those concepts is that not only is nutritional absorption compromised, but medication absorption is as well. The principles of the management of home parenteral nutrition must be mastered and then proper and controlled weaning of parenteral nutrition may be commenced by use of dietary and pharmacologic means with appropriate clinical outcome measures followed. This complicated management requires a team experienced in both medical and surgical management of intestinal failure.
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.006
Modern Management of Acute Liver Failure
- Authors: Ruben Khan; Sean Koppe
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Ruben Khan, Sean Koppe
  Teaser Acute liver failure is a rare but life-threatening disease that can lead to progressive encephalopathy, intracranial hypertension, and multiorgan failure. In the developed world, the most common cause remains acetaminophen overdose, but there are still many cases in which there is acute liver failure of unknown etiology. The mainstay of acute liver failure management remains supportive care in the critical care setting. If supportive treatment does not stabilize the disease process, the patient may require emergent liver transplantation. This article summarizes the current management of acute liver failure.
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.005
Living Donor Intestinal Transplantation
- Authors: Ivo Tzvetanov; Kiara Tulla; Giuseppe D’Amico; Enrico Benedetti
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Ivo Tzvetanov, Kiara Tulla, Giuseppe D’Amico, Enrico Benedetti
  Teaser Living donor intestinal transplantation (LDIT) has been improved leading to results comparable to those obtained with deceased donors. LDIT should be limited to specific indications and patient selection. The best indication is combined living donor intestinal/liver transplantation in pediatric recipients with intestinal and hepatic failure; the virtual elimination of waiting time may avoid the high mortality experienced by candidates on the deceased waiting list. Potentially, LDIT could be used in highly sensitized recipients to allow the application of de-sensitization protocols. In the case of available identical twins or HLA-identical sibling, LDIT has a significant immunologic advantage and should be offered.
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.008
Robotic Pancreas Transplantation
- Authors: Mario Spaggiari; Ivo G. Tzvetanov; Caterina Di Bella; Jose Oberholzer
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Mario Spaggiari, Ivo G. Tzvetanov, Caterina Di Bella, Jose Oberholzer
  Teaser Obesity is considered a relative contraindication to pancreas transplantation due to an overall increased risk in wound-related complications and surgical site infections. The rationale for performing pancreas transplantation in a minimally invasive fashion is to reduce these risks, which can be associated with inferior patient and graft survival following pancreas transplantation in morbidly obese patients. At the University of Illinois at Chicago, the initial series of robotic-assisted pancreas transplantation in obese patient with type 1 and 2 diabetes has been performed. In this article, surgical technique and world experience in robotic pancreas transplantation are described.
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.010
Gastrointestinal Transplantation
- Authors: Enrico Benedetti; Ivo G. Tzvetanov
  Abstract: Publication date: Available online 4 April 2018
  Source:Gastroenterology Clinics of North America
  Author(s): Enrico Benedetti, Ivo G. Tzvetanov
  
  PubDate: 2018-04-15T08:22:11Z
  DOI: 10.1016/j.gtc.2018.01.014
Forthcoming Issues
- Abstract: Publication date: March 2018
  Source:Gastroenterology Clinics of North America, Volume 47, Issue 1
  
  PubDate: 2018-02-15T08:34:54Z
Nutritional Management of Gastrointestinal Diseases
- Authors: Andrew Ukleja
  Abstract: Publication date: Available online 27 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Andrew Ukleja
  
  PubDate: 2018-01-04T22:52:24Z
Nutrition and Disease
- Authors: Alan Buchman
  Abstract: Publication date: Available online 27 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Alan L. Buchman
  
  PubDate: 2018-01-04T22:52:24Z
Complementary and Alternative Medicine in Inflammatory Bowel Disease
- Authors: Ali Keshavarzian; Ece A. Mutlu
  Abstract: Publication date: December 2017
  Source:Gastroenterology Clinics of North America, Volume 46, Issue 4
  Author(s): Ali Keshavarzian, Ece A. Mutlu
  
  PubDate: 2017-12-01T08:17:31Z
  DOI: 10.1016/s0889-8553(17)30126-7
Complementary and Alternative Treatments Are Needed to Enhance the Care of
the Inflammatory Bowel Disease Patient
- Authors: Ali Keshavarzian; Ece A. Mutlu
  Abstract: Publication date: December 2017
  Source:Gastroenterology Clinics of North America, Volume 46, Issue 4
  Author(s): Ali Keshavarzian, Ece A. Mutlu
  
  PubDate: 2017-12-01T08:17:31Z
  DOI: 10.1016/j.gtc.2017.09.001
Use of Complementary and Alternative Medicine in Inflammatory Bowel
Disease Around the World
- Authors: Petros Zezos; Geoffrey C. Nguyen
  Pages: 679 - 688
  Abstract: Publication date: December 2017
  Source:Gastroenterology Clinics of North America, Volume 46, Issue 4
  Author(s): Petros Zezos, Geoffrey C. Nguyen
  Teaser Use of complementary sand alternative medicine (CAM) is common among patients with inflammatory bowel disease (IBD). CAM can be broadly categorized as whole medical systems, mind-body interventions, biologically based therapies, manipulative and body-based methods, and energy therapies. Most do not use it to treat IBD specifically, and most take it as an adjunct to conventional therapy not in place of it. However, patients are frequently uncomfortable initiating a discussion of CAM with their physicians, which may impact adherence to conventional therapy. A greater emphasis on CAM in medical education may facilitate patient-physician discussions regarding CAM.
  
  PubDate: 2017-12-01T08:17:31Z
  DOI: 10.1016/j.gtc.2017.08.001
Complementary and Alternative Medicine Strategies for Therapeutic Gut
Microbiota Modulation in Inflammatory Bowel Disease and their
Next-Generation Approaches
- Authors: Abigail R. Basson; Minh Lam; Fabio Cominelli
  Pages: 689 - 729
  Abstract: Publication date: December 2017
  Source:Gastroenterology Clinics of North America, Volume 46, Issue 4
  Author(s): Abigail R. Basson, Minh Lam, Fabio Cominelli
  Teaser The human gut microbiome exerts a major impact on human health and disease, and therapeutic gut microbiota modulation is now a well-advocated strategy in the management of many diseases, including inflammatory bowel disease (IBD). Scientific and clinical evidence in support of complementary and alternative medicine, in targeting intestinal dysbiosis among patients with IBD, or other disorders, has increased dramatically over the past years. Delivery of “artificial” stool replacements for fecal microbiota transplantation (FMT) could provide an effective, safer alternative to that of human donor stool. Nevertheless, optimum timing of FMT administration in IBD remains unexplored, and future investigations are essential.
  
  PubDate: 2017-12-01T08:17:31Z
  DOI: 10.1016/j.gtc.2017.08.002
Malnutrition in Gastrointestinal Disorders
- Authors: Lori Jane Curtis; Paule Bernier; Khursheed Jeejeebhoy; Johane Allard; Donald Duerksen; Leah Gramlich; Manon Laporte; Heather H. Keller
  Pages: 1391 - 1396
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Khursheed N. Jeejeebhoy, Donald R. Duerksen
  Teaser All patients with significant gastrointestinal disease should be clinically assessed for protein calorie malnutrition by using the Subjective Global Assessment. Blood tests for anemia, electrolytes, calcium, phosphorus, magnesium, ferritin, vitamin B12, and folate should be considered for assessment of major micronutrients. Where malabsorption or inflammatory bowel disease is diagnosed, bone mineral density using dual beam x-ray absorptiometry, 25-OH vitamin D levels, and measurement of other vitamins and trace elements should be considered. In addition, in at-risk patients, vitamin and trace element clinical deficiency syndromes should be considered during patient assessment.
  
  PubDate: 2017-12-12T09:36:56Z
  DOI: 10.1016/j.clnu.2016.09.009
Parenteral Nutrition
- Authors: Brian Lappas; Dhyanesh Patel Vanessa Kumpf Dawn Wiese Adams Douglas
  Abstract: Publication date: Available online 15 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Brian M. Lappas, Dhyanesh Patel, Vanessa Kumpf, Dawn Wiese Adams, Douglas L. Seidner
  Teaser Parenteral nutrition (PN) is a life-sustaining therapy in patients with intestinal failure who are unable to tolerate enteral feedings. Patient selection should be based on a thorough assessment to identify those at high nutrition risk based on both disease severity and nutritional status. This article reviews both the acute and chronic indications for PN as well as special formulation consideration in specific disease states, vascular access, and complications of both short-term and long-term PN.
  
  PubDate: 2017-12-24T18:47:14Z
Enteral Access and Associated Complications
- Authors: Mark DeLegge
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Mark H. DeLegge
  Teaser Enteral access is the foundation for feeding in patients unable to meet their nutrition needs orally and have a functional gastrointestinal tract. Enteral feeding requires placement of a feeding tube. Tubes can be placed through an orifice or percutaneously into the stomach or proximal small intestine at the bedside or in specialized areas of the hospital. Bedside tubes can be placed by the nurse or the physician, such as in the intensive care unit. Percutaneous feeding tubes are placed by the gastroenterologist, surgeon, or radiologist. This article reviews the types of enteral access and the associated complications.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Therapy in Chronic Pancreatitis
- Authors: Enrique Mary; Phillips
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): J. Enrique Domínguez-Muñoz, Mary Phillips
  Teaser Malnutrition is a frequent complication in patients with chronic pancreatitis. Maldigestion as a consequence of pancreatic exocrine insufficiency is the major cause of malnutrition in these patients. Together with that, toxic habits and alterations of the gastroduodenal transit may play a relevant role. Malnutrition in chronic pancreatitis is associated with osteoporosis, sarcopenia, poor quality of life, and increased mortality. An adequate nutritional evaluation including anthropometric, biochemical, and morphologic parameters is recommended in these patients. Nutritional advice and support together with an adequate pancreatic enzyme replacement therapy are indicated.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Therapy in Gastrointestinal Cancers
- Authors: Ronaldo Sousa Oliveira Filho; Priscila Casarin Garla; Raquel Susana Torrinhas; Ricardo Alexandre Garib; Alweyd Tesser; Felipe Garcia Gutierres Aprobato; Erika Midori Tamanaha; Marcia de Souza Antunes; Dan Linetzky Waitzberg
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Priscila Garla, Dan Linetzky Waitzberg, Alweyd Tesser
  Teaser Malnutrition is the most frequent nutritional disorder in patients with gastrointestinal cancer and is associated with cachexia syndrome, worsening of prognosis, and shortened survival rate. Early nutrition screening, assessment, and intervention are able to favorably modify the clinical evolution of affected patients. The adequate provision of nutritional requirements has been associated with improvement of immunologic status, and avoidance of further complications related to poor nutritional status, surgical treatment, and anticancer therapy. In malnourished patients, the supplementation of perioperative immunonutrition might contribute to fewer infectious and noninfectious complications, shorter length of hospitalization, and improved wound healing.
  
  PubDate: 2017-12-12T09:36:56Z
  DOI: 10.1016/j.nut.2017.11.021
Small Intestinal Bacterial Overgrowth
- Authors: Abimbola Adike; John DiBaise
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Abimbola Adike, John K. DiBaise
  Teaser Small intestinal bacterial overgrowth (SIBO), characterized by the presence of excessive bacteria in the small intestine, is typically described as a malabsorptive syndrome occurring in the context of gut stasis syndromes. SIBO is now considered to be a disorder associated with diverse clinical conditions without classic risk factors for SIBO and a cause of several nonspecific gastrointestinal and nongastrointestinal symptoms. Because there is currently no gold standard for diagnosing SIBO, its prevalence and role in the pathogenesis of other diseases remain uncertain; as does optimal treatment of patients with relapsing symptoms.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Consideration in Celiac Disease and Nonceliac Gluten
Sensitivity
- Authors: Rishi Naik; Douglas Seidner Dawn Adams
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Rishi D. Naik, Douglas L. Seidner, Dawn W. Adams
  Teaser Celiac disease is an autoimmune disorder due to the inflammatory response to gluten in genetically predisposed individuals. It causes an enteropathy associated with several nutritional complications. Strict compliance to a gluten-free diet (GFD) is the current primary therapy. Nonceliac gluten sensitivity (NCGS) is a condition in which gluten ingestion leads to systemic symptoms but is not associated with small bowel atrophy or abnormal celiac serologies. A GFD heals celiac disease enteropathy and improves symptoms in NCGS. However, a long-term GFD can be associated with nutritional deficiencies and requires monitoring and guidance.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Interventions in the Patient with Inflammatory Bowel Disease
- Authors: Berkeley Limketkai; Andrea Wolf Joanna Maryam Tajamal Alyssa Parian
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Berkeley N. Limketkai, Andrea Wolf, Joanna Ye, Maryam Tajamal, Alyssa M. Parian
  Teaser Nutritional strategies have been explored as primary or adjunct therapies for inflammatory bowel disease (IBD). Exclusive enteral nutrition is effective for the induction of remission in Crohn disease and is recommended as a first-line therapy for children. Dietary strategies focus on adjusting the ratio of consumed nutrients that are proinflammatory or antiinflammatory. Treatments with dietary supplements focus on the antiinflammatory effects of the individual supplements (eg, curcumin, omega-3 fatty acids, vitamin D) or their positive effects on the intestinal microbiome (eg, prebiotics, probiotics). This article discusses the role of diets and dietary supplements in the treatment of IBD.
  
  PubDate: 2017-12-12T09:36:56Z
The Role of Prebiotics and Probiotics in Gastrointestinal Disease
- Authors: Martin Floch
  Abstract: Publication date: Available online 7 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Martin H. Floch
  Teaser With the advent of the scientific realization that the microbiota of the gastrointestinal tract was more than the cells that exist in the body, the full importance of prebiotics and probiotics has come forth. The importance has been stressed and is available in the new textbook entitled, “The Microbiota in Gastrointestinal Pathophysiology: Implication for Human Health, Prebiotics, Probiotics and Dysbiosis.” There is enough evidence now published in the literature so that the scientific world now believes that prebiotics and probiotics are important in gastrointestinal disease.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Considerations in Liver Disease
- Authors: Asim Shuja; Miguel Malespin James Scolapio
  Abstract: Publication date: Available online 6 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Asim Shuja, Miguel Malespin, James Scolapio
  Teaser Malnutrition occurs in most patients with advanced liver diseases and is associated with higher rates of morbidity and mortality. In this article, the authors discuss the pathophysiology of malnutrition and methods to optimize nutrition status in liver disease and include a brief section on perioperative and postoperative nutrition.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Therapy in Adult Short Bowel Syndrome Patients with Chronic
Intestinal Failure
- Authors: Palle Bekker; Jeppesen Kristian Asp Fuglsang
  Abstract: Publication date: Available online 6 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Palle Bekker Jeppesen, Kristian Asp Fuglsang
  Teaser Intestinal failure (IF) is the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that parenteral support (PS) is required to maintain health and/or growth. This article critically revises the gaps in and evidence for providing general nutritional therapy recommendations in the Short Bowel Syndrome-IF population. It addresses the need for an individualized approach, aiming to reduce or even eliminate the need for PS, and emphasizes a need to focus on effects of dietary interventions on the quality of life of these patients.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Aspects of Acute Pancreatitis
- Authors: Kristen Roberts; Marcia Nahikian-Nelms Andrew Ukleja Luis Lara
  Abstract: Publication date: Available online 6 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Kristen M. Roberts, Marcia Nahikian-Nelms, Andrew Ukleja, Luis F. Lara
  Teaser The goal of nutritional support in acute pancreatitis is to reduce inflammation, prevent nutritional depletion, correct a negative nitrogen balance, and improve outcomes. Enteral nutrition (EN) in severe acute pancreatitis (SAP) should be preferred to parenteral nutrition. It maintains the integrity of the gut barrier, decreases intestinal permeability, downregulates the systemic inflammatory response, maintains intestinal microbiota equilibrium, and reduces the complications of the early phase of SAP, improving morbidity and possibly improving mortality, and it is less expensive. Further studies to understand optimal timing of nutrition, route of delivery of EN, and the type of nutrition and nutrients are necessary.
  
  PubDate: 2017-12-12T09:36:56Z
Nutritional Interventions in Chronic Intestinal Pseudoobstruction
- Authors: Donald Kirby; Sulieman Abdal Raheem Mandy Corrigan
  Abstract: Publication date: Available online 6 December 2017
  Source:Gastroenterology Clinics of North America
  Author(s): Donald F. Kirby, Sulieman Abdal Raheem, Mandy L. Corrigan
  Teaser Although chronic intestinal pseudo-obstruction (CIPO) is a rare disorder, it presents a wide spectrum of severity that ranges from abdominal bloating to severe gastrointestinal dysfunction. In the worst cases, patients may become dependent upon artificial nutrition via parenteral nutrition or choose to have an intestinal transplant. However, whatever the severity, a patient’s quality of life can be seriously compromised. This article defines the disorder and discusses the spectrum of disease and challenges to providing adequate nutrition to help improve a patient’s quality of life.
  
  PubDate: 2017-12-12T09:36:56Z
Forthcoming Issues
- Abstract: Publication date: December 2017
  Source:Gastroenterology Clinics of North America, Volume 46, Issue 4
  
  PubDate: 2017-12-01T08:17:31Z